Skip Navigation

Health: Drug development

Opinions

Here is a list of the latest articles

mycobacterium tuberculosis

Drug-resistant TB needs massive research increase

Multidrug-resistant TB needs more research to equip healthcare workers with the right tools, write Frank G. J. Cobelens and colleagues.

Source: PLoS Medicine

17 July 2008 | EN | 中文

vaccine_Flickr_ciao-chow.jpg

It's a long road to a H5N1 vaccine stockpile

Tadataka Yamada, Alice Dautry and Mark Walport want to see better coordination and financing for a global H5N1 virus vaccine stockpile.

Source: Nature

14 July 2008 | EN | 中文

pregnant-lady-india_Flickr_Meanest-Indian.jpg

Risk-averse researchers put mothers' lives at risk

Researchers are putting women's lives at risk by being too cautious about trialling drugs during pregnancy, say Nicholas J. White and colleagues.

Source: PLoS Medicine

24 June 2008 | EN | 中文

AIDS vaccine

Research deficiencies 'delaying HIV prevention'

Weaknesses in HIV research design have hindered progress in identifying prevention strategies, say Stephen W. Lagakos and Alicia R. Gable.

Source: New England Journal of Medicine

16 April 2008 | EN | 中文

White capsule pills

Prizes, not prices, to stimulate antibiotic R&D

With the worldwide growth of resistance, new antibiotics are increasingly needed. But R&D can be expensive and time-consuming, says James Love.

26 March 2008 | EN | ES | FR | 中文

lymphfilariasis_WHO_TDR_Crumb

Convert Guantanamo to disease research centre

Peter J. Hotez argues that the Guantanamo camp should be converted into a research institute for Latin America's neglected diseases.

Source: PLoS Neglected Tropical Diseases

29 February 2008 | EN | ES | 中文

table of tb drugs

Turning the tide on tuberculosis: a combined effort

The many sponsors of tuberculosis drugs must work together to find new effective treatments, says Mel Spigelman.

4 July 2007 | EN

blue pills

Drug development: litigate less, innovate more

Drug companies seeking to promote research and development in poor nations should focus on innovation, not legislation, argues Angela Saini.

Source: New Scientist

13 April 2007 | EN | 中文

Various pills

Time for home-grown drug development in Brazil

Eliezer Barreiro argues that Brazil should invest in drug development using local materials and talent to reduce its reliance on imports.

Source: Agencia FAPESP

28 November 2006 | ES

White capsule pills

Pharmacogenetics need to go under the microscope

David Weatherall says that pharmacogenetics — or tailor-made medicine — could be the future, but needs to be evaluated carefully before we depart from traditional diagnostic techniques.

15 December 2005 | EN

Leishmania amazonensis parasites

'Open source': a possible cure for neglected diseases

Stephen M. Maurer and colleagues argue that an 'open access' model of drug development, with the products made freely available, could boost the treatment of tropical diseases.

Source: PLoS Medicine

30 December 2004 | EN

rainforest

Little prospect of bioprospecting 'billions'

David Simpson and Roger Sedjo say that governments of developing countries have been misled about the potential value of their biological resources.

Source: Nature

12 August 2004 | EN